Demadex and Photophobia - a phase IV clinical study of FDA data

Summary:

Photophobia is reported as a side effect among people who take Demadex (torsemide), especially for people who are female, 60+ old, also take Neurontin, and have Bronchopulmonary aspergillosis.

The phase IV clinical study analyzes which people have Photophobia when taking Demadex. It is created by eHealthMe based on reports of 5,316 people who have side effects when taking Demadex from the FDA, and is updated regularly.

What is Demadex?

Demadex has active ingredients of torsemide. It is often used in heart failure. eHealthMe is studying from 5,358 Demadex users. Check the latest studies of Demadex.

What is Photophobia?

Photophobia (extreme sensitivity to light) is found to be associated with 1,287 drugs and 1,832 conditions by eHealthMe. Check the latest studies of Photophobia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

5,316 people reported to have side effects when taking Demadex.
Among them, 12 people (0.23%) have Photophobia.

Among these 12 people:

What is the gender of people who have Photophobia when taking Demadex? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Photophobia when taking Demadex? *

What are other drugs people take besides Demadex? *

What are other side effects people have besides Photophobia? *

Cough: 5 people, 41.67%
Abasia (inability to walk): 3 people, 25.00%
Indigestion: 3 people, 25.00%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 3 people, 25.00%
Hair Loss: 3 people, 25.00%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 25.00%
Blood Creatinine Increased: 3 people, 25.00%
High Blood Pressure: 3 people, 25.00%
Vision Blurred: 3 people, 25.00%
Arrhythmias (irregular heartbeat): 3 people, 25.00%

What are the existing conditions these people have? *

Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 3 people, 25.00%
Quit Smoking: 2 people, 16.67%
Pain: 2 people, 16.67%
Ovarian Cancer (cancer of ovary): 2 people, 16.67%
Neuropathy Peripheral (surface nerve damage): 2 people, 16.67%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 8.33%
Peripheral Neuropathy (damage to nerves of the peripheral nervous system): 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%
Asthma: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Demadex and have Photophobia?

- Check whether Photophobia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Demadex:

Demadex (5,358 reports)

Photophobia treatments and more:

Photophobia (21,347 reports)

Browse all side effects of Demadex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Photophobia:

Photophobia (1,287 drugs)

Browse all the conditions that are associated with Photophobia:

Photophobia (1,832 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on torsemide (the active ingredients of Demadex) and Demadex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.